Use your antibodies-online credentials, if available.
Adenosine deaminase type 2 deficiency with a homozygous premature stop codon masquerading as GATA2 deficiency: successful haploidentical sibling hematopoietic stem cell transplantation.
Deficiency of ADA2 (显示 TADA2A 抗体) causes IgA (显示 IgA 抗体)-IgG antibody deficiencies in a family.
High CECR1 activity is associated with brain tumor.
Data show that 2 patients required a second transplant for engraftment failure were discovered to carry the deleterious ADA2 adenosine deaminase (CECR1) mutations and be ADA2 (显示 TADA2A 抗体) deficient.
CECR1 function in (M2-like) macrophages mediates cross talk between macrophages and pericytes in GBM via paracrine PDGFB-PDGFRbeta signaling, promoting pericyte recruitment and migration, and tumor angiogenesis.
We discuss three newly described monogenic autoinflammatory diseases [deficiency of adenosine deaminase 2 (DADA2), a subtype of macrophage activation syndrome (MAS (显示 MAS1 抗体)), and stimulator of interferon genes (STING)-associated vasculopathy with onset in infancy (SAVI)], discuss the possibilities of somatic mosaicism and digenic inheritance, and give an update on new concepts in pathways involved in familial Mediterranean fever (显示 MEFV 抗体)
Findings indicate that ADA2 (显示 TADA2A 抗体) deficiency presents not only with vasculopathy but also with an immunodeficiency of the B cell compartment. Therefore, patients with antibody deficiency should be screened for ADA2 (显示 TADA2A 抗体) deficiency.
The clinical manifestations of adenosine deaminase 2 deficiency ranged in severity from limited cutaneous involvement to severe multisystemic vasculitis; one-third of our cases (5 of 15) were currently asymptomatic, and required close monitoring. We recommend CECR1 screening for unaffected siblings of index cases, cases of familial vasculitis, and cases of PAN (显示 SUPT6H 抗体) that is resistant to standard treatment
Deficiency of Adenosine Deaminase 2 (DADA2) is a new autoinflammatory disease secondary to autosomal recessive mutations of CECR1 (Cat Eye Syndrome Chromosome Region 1) gene, mapped to chromosome 22q11.1.
IL-17 receptor A (显示 IL17RA 抗体) and adenosine deaminase 2 deficiency due to deletion mutations was found in siblings with chronic mucocutaneous candidiasis and chronic systemic inflammation.
Increased ADA2 expression and activity are identified in human and porcine retinas with diabetes.
This gene encodes a member of a subfamily of the adenosine deaminase protein family. The encoded protein may act as a growth factor and have adenosine deaminase activity. It may be responsible for some of the phenotypic features associated with cat eye syndrome. Two transcript variants encoding distinct isoforms have been identified for this gene.
, adenosine deaminase CECR1-A
, cat eye syndrome chromosome region, candidate 1
, cat eye syndrome critical region protein 1 homolog A
, adenosine deaminase CECR1
, cat eye syndrome critical region protein 1-like
, cat eye syndrome critical region protein 1
, insect-derived growth factor-B-like protein
, adenosine deaminase 2
, Cat eye syndrome critical region protein 1 homolog